Cytarabine (Ara-C) Clinical Trials
5 recruitingDrug
Phase 23Early Phase 11Phase 31
Showing 1–5 of 5 trials
Recruiting
Phase 3
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Acute Myeloid Leukemia (AML)
Kura Oncology, Inc.1,300 enrolled39 locationsNCT07007312
Recruiting
Early Phase 1
UPDATE AML: UPdated Disease Monitoring And Treatment for Enhanced Outcomes for Pediatric AML
Acute Myeloid LeukemiaPediatric AML
Joanna Yi36 enrolled1 locationNCT07059975
Recruiting
Phase 2
Efficacy and Safety of Low-Dose Cytarabine Combined With Thalidomide in Adult Patients With Untreated LCH
Langerhans Cell Histiocytosis
Cancer Institute and Hospital, Chinese Academy of Medical Sciences50 enrolled1 locationNCT07187193
Recruiting
Phase 2
Venetoclax-containing Therapy Combined With Microtransplant for Newly Diagnosed AML
Acute Myeloid Leukemia
Beijing 302 Hospital50 enrolled1 locationNCT07078591
Recruiting
Phase 2
VHAG in Treating R/R T-ALL/LBL
Acute T Lymphpblastic Leukemia/Lymphoma
First Affiliated Hospital of Zhejiang University50 enrolled1 locationNCT06742463